Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery

Obstetrics and Gynecology

Volumn 116, Issue 1, 2010, Pages 58-62

  Haddow, James E ^a   Cleary Goldman, Jane ^b   McClain, Monica R ^b   Palomaki, Glenn E ^b   Neveux, Louis M ^b   Lambert Messerlian, Geralyn ^b   Canick, Jacob A ^b   Malone, Fergal D ^b   Porter, T Flint ^b   Nyberg, David A ^b   Bernstein, Peter S ^b   D'Alton, Mary E ^b  

^a BROWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOTHYROIDISM; INFLAMMATION; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; IODIDE PEROXIDASE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 77954038273     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e10b30     Document Type: Article

References (10)

1. Stagnaro-Green A. Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 2009;94:21-25
2. Glinoer D, Riahi M, Grun JP, Kinthaert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 1994;79: 197-204.
3. Ghafoor F, Mansoor M, Malik T, Malik MS, Khan AU, Edwards R, et al. Role of thyroid peroxidase antibodies in the outcome of pregnancy. J Coll Physicians Surg Pak 2006;16: 468-471
4. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587-2591
5. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997;90:364-369
6. Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009;94:772-779
7. Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, et al. First-and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First-and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 2008;199:62.e1-6
8. McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, et al. Sequential first-and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol 2008;199:129.e1-6
9. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunc-tion and pregnancy outcome. Obstet Gynecol 2008;112:85-92.
10. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011